Beacon
Charlie de Lanoy Meijer has extensive experience in sales and research within various industries, currently serving as a Sales Development Representative at Beacon Targeted Therapies since November 2022. In this role, Charlie supports biotechs and pharmaceutical companies by providing insights through a comprehensive database to help inform strategic decisions. Previously, Charlie worked as a Delegate Sales Executive at Hanson Wade and as a Researcher at flypop, focusing on sustainable fuel policies. Additional experience includes internships and short-term roles in sales and production, alongside a solid academic background in Biology from the University of Bristol, specializing in Genetics, Molecular Biology, and Ecology.
Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape. With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.